September 2024 Volume 20, Issue 5

Volume 20, Issue 5 | September 2024
September 2024
In this Issue
Neuroscience

Developing new drugs to treat addiction
No pharmaceutical treatments exist for addictions to drugs like cocaine or cannabis. Now, scientists are engineering gene therapies, immunotherapies, and more.
Lighting the way to pain relief
Rodent studies and clinical trials increasingly demonstrate the soothing effects of green light, and now, researchers are revealing the underlying neural mechanisms.Infectious Disease

Predicting protection for maternal GBS vaccines
A new model predicts how well maternal vaccines protect babies from Group B Streptococcus, propelling much needed shots through late-stage clinical trials.
How monkeys revealed a schistosomiasis vaccine secret
There is no vaccine against this parasitic worm infection, but rhesus macaques’ unique immune system has brought the prospect of a vaccine closer than ever.Biomarkers

Preventing autoimmune disease
Once symptoms show up, it’s too late to cure many autoimmune diseases. Researchers are investigating ways to prevent the conditions from starting at all.
A spitting image of brain health
A saliva-based test could make it easier to diagnose concussions.Drug Formulation

A squishy solution for smoother drug delivery
Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.
A new gel to prevent skin cancer without toxicity
Avoiding skin cancer could be as easy as slathering on a gel that the body rapidly metabolizes.Editors Insight

Overhyping science breeds false hope
Scientists and science journalists alike have a responsibility to communicate new discoveries with the utmost accuracy, sans hype.Editor's Focus

Uncovering unknown tumor antigens
Detecting tumor antigens is key to developing effective cancer diagnostics, immunotherapies, and vaccines.

Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe